HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Vincamine Supplement Cleared For Short-Term Adult Use

This article was originally published in The Tan Sheet

Executive Summary

A dietary supplement providing up to 20 mg of vincamine per day is reasonably expected to be safe when consumed by healthy adults for up to six months, FDA says in a letter to GNC recently made available by the agency.

You may also be interested in...



Jarrow Formulas' Vinpocetine Claim Cited In FDA "Courtesy" Letter

Jarrow Formulas' Vinpocetine 5 mg is cited by FDA in a Sept. 8 "courtesy" letter for making a structure/ function claim referring to "brain metabolism."

GNC Vincamine New Dietary Ingredient Safety Notice To Be Resubmitted

General Nutrition Corporation plans to resubmit its new dietary ingredient premarket notification to FDA for a derivative of vinca minor (periwinkle) called vincamine.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel